Blood News and Research

RSS

Prostate cancer patients more likely to receive medical care matched to level of risk

After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco.

25 Jul 2015

Ben Taub Hospital building national reputation for cardiovascular services

For most of the day, Graciela Del Angel felt shortness of breath and a tightness in her chest. Though her symptoms were uncomfortable, they became unbearable about midnight. By then, she had difficulty breathing and deep chest pains—all signs of a heart attack.

25 Jul 2015

NEJM suggests use of HCV-positive kidneys as one solution to kidney shortage

The average wait time for a kidney transplant is five years and there are more than 100,000 people on the waiting list. However, there are thousands of viable hepatitis C-positive kidneys that are discarded each year solely because they're infected.

25 Jul 2015

Higher case volume linked with improved outcomes for catheter-based blood clot removal in LE-DVT patients

Patients who have lower extremity proximal deep vein thrombosis (LE-DVT), or a blood clot in their leg, are increasingly undergoing minimally invasive catheter-based blood clot removal - also referred to as catheter-directed thrombolysis (CDT) - rather than solely being treated with traditional blood-thinning medications (anticoagulation alone).

25 Jul 2015

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis today announced the US Food and Drug Administration has approved Odomzo (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

25 Jul 2015

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.

25 Jul 2015

Extremes of stroke symptoms attract misdiagnoses

Patients with very mild or very severe stroke symptoms are at the greatest risk of being misdiagnosed in the emergency department, research suggests.

24 Jul 2015

New study reveals protein's critical role in development and progression of AML

A new study by researchers at University of California, San Diego School of Medicine reveals a protein's critical - and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.

24 Jul 2015

V-PPRN approved to receive $1.4 million to participate in second phase of PCORnet

The Vasculitis Patient-Powered Research Network, led by Peter A. Merkel, MD, MPH, Professor of Medicine and Epidemiology at the University of Pennsylvania and George Casey, MBA, Vice President of the Vasculitis Foundation, has been approved to receive a three-year $1.4 million award by the Patient-Centered Outcomes Research Institute as part of the second phase of the National Patient-Centered Clinical Research Network.

24 Jul 2015

Researchers find way to reverse clotting factor deficiency that triggers hemophilia A

Sufferers of hemophilia live in a perpetual state of stress and anxiety: their joints wear down prematurely and they have bleeding episodes that feel like they will never end. Their bodies lack the ability to make the clotting factor responsible for the coagulation of blood so any cut or bruise can turn into an emergency without immediate treatment.

24 Jul 2015

3SBio purchases entire equity interest in Zhejiang Wansheng

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the entire equity interest in Zhejiang Wansheng Pharmaceutical Co., Ltd a limited liability company incorporated in the PRC for an aggregate consideration of RMB 528 million.

24 Jul 2015

PEth biomarker significantly higher in binge drinkers

A biomarker found in the blood of alcohol users is significantly higher in binge drinkers than in those who consume alcohol moderately, according to a study by researchers at the University of Illinois at Chicago. The biomarker, called phosphatidylethanol (PEth), could be used to screen young adults for harmful or heavy drinking such as binge drinking.

24 Jul 2015

Stem cell transplantation improves outcomes in children with rare form of chronic blood cancer

Researchers in the Division of Hematology, Oncology and Blood & Marrow Transplantation at Children's Hospital Los Angeles have shown greatly improved outcomes in using stem cell transplantation to treat patients with a serious but very rare form of chronic blood cancer called juvenile myelomonocytic leukemia (JMML).

24 Jul 2015

Moffitt researchers develop genetic test that analyzes sensitivity of tumors to radiation therapy

Recent advances in the understanding of cancer have led to more personalized therapies, such as drugs that target particular proteins and tests that analyze gene expression patterns in tumors to predict a patient's response to therapy.

24 Jul 2015

Two UM researchers receive $500,000 to improve treatment for mild traumatic brain injury

Two University of Montana researchers were among six final winners nationally to receive $500,000 from the Head Health Challenge I, an up-to-$10 million program sponsored by General Electric Co. and the National Football League.

24 Jul 2015

MSU scientists suggest that common glaucoma medication could be used to treat TB

A new discovery by Michigan State University scientists suggests that a common medication used to treat glaucoma could also be used to treat tuberculosis, even the drug-resistant kind.

24 Jul 2015

New Penn study finds link between graduate medical training and brand name statin prescribing

Physicians in training are twice as likely to order a costly brand-name statin (used to lower blood cholesterol levels) when supervised by senior physicians who prefer those medications in their own practice, according to a new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and published online in the Journal of General Internal Medicine.

24 Jul 2015

Mayo Clinic researchers study HDAC inhibitors to find effective treatments for anaplastic thyroid cancer

In their bid to find the best combination of therapies to treat anaplastic thyroid cancer (ATC), researchers on Mayo Clinic's Florida campus demonstrated that all histone deacetylase (HDAC) inhibitors are not created equal.

24 Jul 2015

Less invasive endovascular aortic repair benefits most patients, provides quick recovery

Each year, nearly 40,000 Americans undergo elective surgery to repair an abdominal aortic aneurysm with the goal of preventing a life-threatening rupture of this potentially dangerous cardiovascular condition.

24 Jul 2015

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Amgen today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Kyprolis (carfilzomib) for Injection to seek an expanded indication for the treatment of patients with a form of blood cancer, relapsed multiple myeloma, who have received at least one prior therapy.

23 Jul 2015

Blood News and Research

Prostate cancer patients more likely to receive medical care matched to level of risk

Ben Taub Hospital building national reputation for cardiovascular services

NEJM suggests use of HCV-positive kidneys as one solution to kidney shortage

Higher case volume linked with improved outcomes for catheter-based blood clot removal in LE-DVT patients

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

Extremes of stroke symptoms attract misdiagnoses

New study reveals protein's critical role in development and progression of AML

V-PPRN approved to receive $1.4 million to participate in second phase of PCORnet

Researchers find way to reverse clotting factor deficiency that triggers hemophilia A

3SBio purchases entire equity interest in Zhejiang Wansheng

PEth biomarker significantly higher in binge drinkers

Stem cell transplantation improves outcomes in children with rare form of chronic blood cancer

Moffitt researchers develop genetic test that analyzes sensitivity of tumors to radiation therapy

Two UM researchers receive $500,000 to improve treatment for mild traumatic brain injury

MSU scientists suggest that common glaucoma medication could be used to treat TB

New Penn study finds link between graduate medical training and brand name statin prescribing

Mayo Clinic researchers study HDAC inhibitors to find effective treatments for anaplastic thyroid cancer

Less invasive endovascular aortic repair benefits most patients, provides quick recovery

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News